The YAP1-NPM1 nuclear complex regulates MYC and reveals a targetable oncogenic node

Abdulrahman M Dwead1,2, Marwah M Al-Mathkour1,3, Maxim Khanov4

  • 1Department of Biological Sciences and Center for Cancer Research and Therapeutic Development, Clark Atlanta University, Atlanta, GA 30314, USA.

Iscience
|May 11, 2026
PubMed

Insights

Yes-associated protein 1 (YAP1) and nucleophosmin 1 (NPM1) form a complex in prostate cancer. Inhibiting NPM1 disrupts this axis, suppressing cancer growth and offering new therapeutic strategies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Yes-associated protein 1 (YAP1) and nucleophosmin 1 (NPM1) are proteins with known cellular functions.
  • Their combined roles in cancer development are not well understood.

Purpose of the Study:

  • To investigate the interaction between YAP1 and NPM1 in prostate cancer.
  • To determine the functional consequences of this interaction and its potential as a therapeutic target.

Main Methods:

  • Proteomics, co-immunoprecipitation, proximity ligation, and GST-pulldown assays were used to detect the YAP1-NPM1 complex.
  • Androgen signaling modulation was studied in androgen receptor-positive cells.
  • Genetic and pharmacologic inhibition of NPM1 was performed.
  • Prostate tumor samples were analyzed using immunological and computational methods.

Main Results:

  • YAP1 and NPM1 form a direct nuclear protein complex in prostate cancer cells and tissues.
  • Androgen signaling influences the YAP1-NPM1 interaction.
  • NPM1 inhibition disrupts the complex, reduces YAP1 and MYC expression, and inhibits cell proliferation and motility.
  • Elevated YAP1 and NPM1 expression and interaction correlate with prostate cancer progression.

Conclusions:

  • The YAP1-NPM1 axis is a critical regulator in prostate cancer, integrating oncogenic pathways.
  • This axis represents a potential therapeutic vulnerability.
  • Targeting the YAP1-NPM1 axis may improve androgen receptor-directed therapies for advanced prostate cancer.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Regulation of Nuclear Protein Sorting01:45

Regulation of Nuclear Protein Sorting

Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...